The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV

Int J Tuberc Lung Dis. 2024 Jan 1;28(1):1-2. doi: 10.5588/ijtld.23.0570.
No abstract available

MeSH terms

  • Antitubercular Agents* / therapeutic use
  • HIV Infections* / drug therapy
  • HIV Infections* / prevention & control
  • Humans
  • Isoniazid

Substances

  • Antitubercular Agents
  • Isoniazid